Posted by Michael Wonder on 02 Oct 2019
Lamotrigine brand change from today
1 October 2019 - From today there will be one funded brand of lamotrigine - a medicine used to treat epilepsy and some mental health conditions, including bipolar disorder.
There are several suppliers that make lamotrigine – each with their own brand. PHARMAC has decided to change from funding three different brands (Lamictal, Arrow-Lamotrigine and Logem) to funding the Logem brand only.
Before making this decision PHARMAC got expert advice from healthcare professionals who work directly with people with epilepsy and mental health conditions to make sure it’s appropriate for people to change brands of lamotrigine.
